COMMUNIQUÉS West-GlobeNewswire

Applied Therapeutics Reports First Quarter 2019 Financial Results
21/06/2019
-Strengthened Financial Position with Recent Initial Public Offering- - Phase 1/2 Trial AT-007 in Adults with Galactosemia Expected to Start This Month - - Pivotal Phase 2/3 Trial for AT-001 in Diabetic Cardiomyopathy [...]
Nabriva Therapeutics to Present Data at ASM Microbe Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO™ (fosfomycin) for injection to Treat Complicated Urinary Tract Infections (cUTIs)
21/06/2019
DUBLIN, Ireland, June 21, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious [...]
Fête nationale du Québec
21/06/2019
L’alcool, une arme redoutable à double tranchant pour la santé MONTRÉAL, 21 juin 2019 (GLOBE NEWSWIRE) -- À l’approche de la Fête nationale du Québec , la Fondation de l’Institut de Cardiologie de Montréal fait le point [...]
AgraFlora Organics Secures 51,500 Sq. Ft Edibles Manufacturing Facility; Anticipates Q1 2020 Receipt of Health Canada Sales and Processing Licenses
21/06/2019
VANCOUVER, British Columbia, June 21, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Zealand Pharma introduces new website to support people living with short bowel syndrome
21/06/2019
Press release – No. 15 / 2019 Zealand Pharma introduces new website to support people living with short bowel syndrome LivingWithSBS.com is a new website with information about short bowel syndrome, drawing from [...]
Wildflower mise en avant dans la publication de NetworkNewsWire soulignant les bénéfices incroyables générés par le cannabis
21/06/2019
NEW YORK, 21 juin 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) a annoncé aujourd'hui son apparition dans une rubrique éditoriale publiée par NetworkNewsWire (« NNW »), [...]
Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma
21/06/2019
Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma REGN3500 (SAR440340) monotherapy significantly reduced loss of asthma control and improved lung function compared to placebo [...]
Sanofi et Regeneron annoncent les premiers résultats positifs de phase II de leur anticorps anti-IL-33 dans le traitement de l’asthme
21/06/2019
Sanofi et Regeneron annoncent les premiers résultats positifs de phase II de leur anticorps anti-IL-33 dans le traitement de l’asthme REGN3500 (SAR440340) en monothérapie a significativement réduit le risque de perte de [...]
ObsEva SA to Present Nolasiban and Linzagolix Clinical Data at the ESHRE Annual Meeting June 23-26 in Vienna
21/06/2019
Geneva, Switzerland and Boston, MA – June 21, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
21/06/2019
Regulated information Gosselies, Belgium, 21 June 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
21/06/2019
Information réglementée Gosselies, Belgique, le 21 juin 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Axcella Health Reports First Quarter 2019 Financial Results and Provides Company Update
20/06/2019
Successfully completed initial public offering, raising $71.4 million in gross proceeds Presented data on AXA1665 and AXA1125 at two leading medical conferences Identified drug development path for AXA1665 following the [...]
Akcea and Ionis Announce Upcoming Data Presentations at the 2019 Peripheral Nerve Society Annual Meeting
20/06/2019
Multiple clinical presentations focus on the long-term clinical benefits of treatment with TEGSEDI® (inotersen) BOSTON and CARLSBAD, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an [...]
ContraVir Pharmaceuticals Receives Positive FDA Response to CRV431 Pre-IND Package for NASH
20/06/2019
Feedback Supports Preclinical and Clinical Development Plan and Planned IND Filing for CRV431 for NASH EDISON, N.J., June 20, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical [...]
Geron Appoints Vice President, Human Resources
20/06/2019
MENLO PARK, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointment of Shannon Odam as Vice President, Human Resources. Ms. Odam joins other recently recruited senior [...]
IBRI in license agreement for access to Lilly’s Fab Phage Display Library
20/06/2019
Will speed the discovery and validation of new antibodies to improve human health INDIANAPOLIS, June 20, 2019 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced it has entered into a [...]
Selecta Biosciences Announces Appointment of Scott D. Myers to Board of Directors
20/06/2019
WATERTOWN, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune [...]
Galapagos increases share capital through warrant exercises
20/06/2019
Mechelen, Belgium; 20 June 2019, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 208,310 new ordinary [...]
Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D
20/06/2019
Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D Investor/analyst conference call tomorrow at 09:30 CEST Saint Herblain (France), June 20, 2019 – Valneva SE (“ [...]

Pages